CD44 and gastric cancer: While another study argues that upregulated CD133 is not correlated to N stage or differentiation type.[16] Based on these controversial studies, a meta-analysis was conducted to evaluate the precise impact of CD44 and CD133 on pathology and prognosis of gastric cancer.